Animal models in carotenoids research and lung cancer prevention

Translational Oncology

Volumn 4, Issue 5, 2011, Pages 271-281

  Kim, Jina ^a   Kim, Yuri ^a  

^a Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA TOCOPHEROL; APO 10' LYCOPENOIC ACID; ASCORBIC ACID; ASCORBYL PALMITATE; BETA CAROTENE; BETA CRYPTOXANTHIN; CALCITRIOL; CIGARETTE SMOKE; CYTOCHROME P450; GAMMA TOCOPHEROL; HESPERIDIN; LYCOPENE; RETINOIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CANCER PREVENTION; CANCER RISK; CIGARETTE SMOKING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; LUNG CANCER; LUNG CARCINOGENESIS; NONHUMAN;

EID: 80053379339     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.11184     Document Type: Article

References (139)

1. Jemal A, Siegel R, Xu J, and Ward E (2010). Cancer statistics. CA Cancer J Clin 60, 277-300.
2. Mayne ST (1996). β-Carotene, carotenoids, and disease prevention in humans. FASEB J 10, 690-701.
3. Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, et al. (2008). The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acids, carotenoids, α-tocopherol, selenium, and total peroxyl radical absorbing capacity. Am J Epidemiol 168, 831-840.
4. Yuan JM, Ross RK, Chu XD, Gao YT, and Yu MC (2001). Prediagnostic levels of serum β-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol Biomarkers Prev 10, 767-773.
5. Yuan JM, Stram DO, Arakawa K, Lee HP, and Yu MC (2003). Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 12, 890-898.
6. Giovannucci E (1999). Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 91, 317-331.
7. Travis WD (2002). Pathology of lung cancer. Clin Chest Med 23, 65-81, viii.
8. Kim Y, Liu XS, Liu C, Smith DE, Russell RM, and Wang XD (2006). Induction of pulmonary neoplasia in the smoke-exposed ferret by 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK): a model for human lung cancer. Cancer Lett 234, 209-219.
9. Colby TV, Wistuba II, and Gazdar A (1998). Precursors to pulmonary neoplasia. Adv Anat Pathol 5, 205-215.
10. Reznik-Schuller H (1975). Ciliary alterations in hamster respiratory tract epithelium after exposure to carcinogens and cigarette smoke. Cancer Lett 1, 7-13.
11. Hecht SS (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91, 1194-1210.
12. Hecht SS (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3, 733-744.
13. Hecht SS, Kassie F, and Hatsukami DK (2009). Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat Rev Cancer 9, 476-488.
14. Nakayama T, Kodama M, and Nagata C (1984). Generation of hydrogen peroxide and superoxide anion radical from cigarette smoke. Gann 75, 95-98.
15. Rojas E, Valverde M, Sordo M, and Ostrosky-Wegman P (1996). DNA damage in exfoliated buccal cells of smokers assessed by the single cell gel electrophoresis assay. Mutat Res 370, 115-120.
16. Wang X-D (2004). Carotenoid oxidative/degradative products and their biological activities. In Carotenoids in Health and Disease. NI Krinsky (Ed). Marcel Dekker, New York, NY. pp. 313-335.
17. Goodman DS and Huang HS (1965). Biosynthesis of vitamin A with rat intestinal enzymes. Science 149, 879-880.
18. Olson JA and Hayaishi O (1965). The enzymatic cleavage of β-carotene into vitamin A by soluble enzymes of rat liver and intestine. Proc Natl Acad Sci USA 54, 1364-1370.
19. Krinsky NI (1993). Actions of carotenoids in biological systems. Annu Rev Nutr 13, 561-587.
20. Burton GW and Ingold KU (1984). β-Carotene: an unusual type of lipid antioxidant. Science 224, 569-573.
21. Napoli JL and Race KR (1988). Biogenesis of retinoic acid from β-carotene. Differences between the metabolism of β-carotene and retinal. J Biol Chem 263, 17372-17377.
22. Wang XD and Krinsky NI (1998). The bioconversion of β-carotene into retinoids. Subcell Biochem 30, 159-180.
23. Sies H and Stahl W (1997). Carotenoids and intercellular communication via gap junctions. Int J Vitam Nutr Res 67, 364-367.
24. Zhang LX, Cooney RV, and Bertram JS (1991). Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12, 2109-2114.
25. Stahl W and Eisenbrand G (1991). Comparative study on the influence of two 2-chloroethylnitrosoureas with different carbamoylating potential towards glutathione and glutathione-related enzymes in different organs of the rat. Free Radic Res Commun 14, 271-278.
26. Santos MS, Meydani SN, Leka L, Wu D, Fotouhi N, Meydani M, Hennekens CH, and Gaziano JM (1996). Natural killer cell activity in elderly men is enhanced by β-carotene supplementation. Am J Clin Nutr 64, 772-777.
27. Watson RR, Prabhala RH, Plezia PM, and Alberts DS (1991). Effect of β-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr 53, 90-94.
28. Hughes DA (1999). Effects of carotenoids on human immune function. Proc Nutr Soc 58, 713-718.
29. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, Zick A, Sharoni Y, and Levy J (2005). Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4, 177-186.
30. Stahl W, von Laar J, Martin D, Emmerich T, and Sies H (2000). Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch Biochem Biophys 373, 271-274.
31. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, and Sharoni Y (2000). Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36, 101-111.
32. Edes TE, Thornton W Jr, and Shah J (1989). β-Carotene and aryl hydrocarbon hydroxylase in the rat: an effect of β-carotene independent of vitamin A activity. J Nutr 119, 796-799.
33. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, et al. (1996). α-Tocopherol and β-carotene supplements and lung cancer incidence in the α-tocopherol, β-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88, 1560-1570.
34. Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack MG, Cullen MR, Glass A, et al. (1994). The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 54, 2038s-2043s.
35. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, et al. (1996). Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150-1155.
36. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, et al. (1996). Risk factors for lung cancer and for intervention effects in CARET, the β-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88, 1550-1559.
37. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, et al. (1996). Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149.
38. Kim Y, Chongviriyaphan N, Liu C, Russell RM, andWang XD (2006). Combined antioxidant (β-carotene, α-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model. Carcinogenesis 27, 1410-1419.
39. Liu C, Lian F, Smith DE, Russell RM, and Wang XD (2003). Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smokeexposed ferrets. Cancer Res 63, 3138-3144.
40. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, and Russell M (1999). Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 91, 60-66.
41. Liu C, Russell RM, and Wang XD (2006). Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J Nutr 136, 106-111.
42. Wang XD, Krinsky NI, Marini RP, Tang G, Yu J, Hurley R, Fox G, and Russell RM (1992). Intestinal uptake and lymphatic absorption of β-carotene in ferrets: a model for human β-carotene metabolism. Am J Physiol 263, G480-G486.
43. Gugger ET, Bierer TL, Henze TM, White WS, and Erdman JW Jr (1992). β-Carotene uptake and tissue distribution in ferrets (Mustela putorius furo). J Nutr 122, 115-119.
44. Wang XD, Tang GW, Fox JG, Krinsky NI, and Russell RM (1991). Enzymatic conversion of β-carotene into β-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues. Arch Biochem Biophys 285, 8-16.
45. Wang XD, Russell RM, Marini RP, Tang G, Dolnikowski GG, Fox JG, and Krinsky NI (1993). Intestinal perfusion of β-carotene in the ferret raises retinoic acid level in portal blood. Biochim Biophys Acta 1167, 159-164.
46. Wang XD, Russell RM, Liu C, Stickel F, Smith DE, and Krinsky NI (1996). β-Oxidation in rabbit liver in vitro and in the perfused ferret liver contributes to retinoic acid biosynthesis from β-apocarotenoic acids. J Biol Chem 271, 26490-26498.
47. Liu C, Wang XD, Bronson RT, Smith DE, Krinsky NI, and Russell RM (2000). Effects of physiological versus pharmacological β-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis 21, 2245-2253.
48. McDowell EM, McLaughlin JS, Merenyl DK, Kieffer RF, Harris CC, and Trump BF (1978). The respiratory epithelium. V. Histogenesis of lung carcinomas in the human. J Natl Cancer Inst 61, 587-606.
49. Brambilla E, Moro D, Veale D, Brichon PY, Stoebner P, Paramelle B, and Brambilla C (1992). Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 23, 993-1003.
50. Wang XD, Krinsky NI, Tang GW, and Russell RM (1992). Retinoic acid can be produced from excentric cleavage of β-carotene in human intestinal mucosa. Arch Biochem Biophys 293, 298-304.
51. van Helden YG, Keijer J, Heil SG, Pico C, Palou A, Oliver P, Munnia A, Briede JJ, Peluso M, Franssen-van Hal NL, et al. (2009). β-Carotene affects oxidative stress- related DNA damage in lung epithelial cells and in ferret lung. Carcinogenesis 30, 2070-2076.
52. Kim Y, Lian F, Yeum KJ, Chongviriyaphan N, Choi SW, Russell RM, and Wang XD (2007). The effects of combined antioxidant (β-carotene, α-tocopherol and ascorbic acid) supplementation on antioxidant capacity, DNA single-strand breaks and levels of insulin-like growth factor-1/IGF-binding protein 3 in the ferret model of lung cancer. Int J Cancer 120, 1847-1854.
53. Fuster A, Pico C, Sanchez J, Oliver P, Zingaretti MC, Murano I, Morroni M, Hoeller U, Goralczyk R, Cinti S, et al. (2008). Effects of 6-month daily supplementation with oral β-carotene in combination or not with benzo[a]pyrene on cell-cycle markers in the lung of ferrets. J Nutr Biochem 19, 295-304.
54. Liu C, Bronson RT, Russell RM, and Wang XD (2011). β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage and squamous metaplasia in ferrets. Cancer Prev Res (Phila), Epub ahead of print.
55. Goralczyk R (2009). β-Carotene and lung cancer in smokers: review of hypotheses and status of research. Nutr Cancer 61, 767-774.
56. Bruder CE, Yao S, Larson F, Camp JV, Tapp R, McBrayer A, Powers N, Granda WV, and Jonsson CB (2010). Transcriptome sequencing and development of an expression microarray platform for the domestic ferret. BMC Genomics 11, 251.
57. Ferreira AL, Yeum KJ, Liu C, Smith D, Krinsky NI, Wang XD, and Russell RM (2000). Tissue distribution of lycopene in ferrets and rats after lycopene supplementation. J Nutr 130, 1256-1260.
58. Johansson MB and Karlsson BW (1976). Lipoproteins in serum of rat, mouse, gerbil, rabbit, pig and man studied by electrophoretical and immunological methods. Comp Biochem Physiol B 54, 495-500.
59. Tsuda H, Iwahori Y, Asamoto M, Baba-Toriyama H, Hori T, Kim DJ, Uehara N, Iigo M, Takasuka N, Murakoshi M, et al. (1996). Demonstration of organotropic effects of chemopreventive agents in multiorgan carcinogenesis models. IARC Sci Publ, 143-150.
60. Wang Y, Zhang Z, Yan Y, Lemon WJ, LaRegina M, Morrison C, Lubet R, and You M (2004). A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res 64, 1647-1654.
61. Limpens J, Schroder FH, de Ridder CM, Bolder CA, Wildhagen MF, Obermuller-Jevic UC, Kramer K, and van Weerden WM (2006). Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J Nutr 136, 1287-1293.
62. Karmakar S, Banik NL, and Ray SK (2008). Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 112, 596-607.
63. Jang SH, Ryu PD, and Lee SY (2011). Dendrotoxin-κ suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice. J Vet Sci 12, 35-40.
64. Meng J, Dai B, Fang B, Bekele BN, Bornmann WG, Sun D, Peng Z, Herbst RS, Papadimitrakopoulou V, Minna JD, et al. (2010). Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo. PLoS One 5, e14124.
65. Lu G, Xiao H, Li GX, Picinich SC, Chen YK, Liu A, Lee MJ, Loy S, and Yang CS (2010). A γ-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth. Carcinogenesis 31, 687-694.
66. Huang CS, Liao JW, and Hu ML (2008). Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J Nutr 138, 538-543.
67. Schleicher RL, Moon RC, Patel MK, and Beattie CW (1988). Influence of retinoids on growth and metastasis of hamster melanoma in athymic mice. Cancer Res 48, 1465-1469.
68. Hecht SS (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11, 559-603.
69. Witschi H (2003). Chemoprevention of lung cancer. Methods Mol Med 75, 739-754.
70. Freemantle SJ and Dmitrovsky E (2010). Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention. Cancer Prev Res (Phila) 3, 1513-1518.
71. Goralczyk R, Wertz K, Lenz B, Riss G, Buchwald Hunziker P, Geatrix B, Aebischer P, and Bachmann H (2005). β-Carotene interaction with NNK in the AJ-mouse model: effects on cell proliferation, tumor formation and retinoic acid responsive genes. Biochim Biophys Acta 1740, 179-188.
72. Lian F, Smith DE, Ernst H, Russell RM, and Wang XD (2007). Apo-10′- lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 28, 1567-1574.
73. Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV, and Upadhyaya P (1999). Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 137, 123-130.
74. Guttenplan JB, Chen M, Kosinska W, Thompson S, Zhao Z, and Cohen LA (2001). Effects of a lycopene-rich diet on spontaneous and benzo[a]pyreneinduced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett 164, 1-6.
75. Mernitz H, Smith DE, Zhu AX, and Wang XD (2006). 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-β but no change in cyclooxygenase-2. Cancer Lett 244, 101-108.
76. Mernitz H, Smith DE, Wood RJ, Russell RM, and Wang XD (2007). Inhibition of lung carcinogenesis by 1α,25-dihydroxyvitamin D3 and 9-cis retinoic acid in the A/J mouse model: evidence of retinoid mitigation of vitamin D toxicity. Int J Cancer 120, 1402-1409.
77. Kohno H, Taima M, Sumida T, Azuma Y, Ogawa H, and Tanaka T (2001). Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett 174, 141-150.
78. Lubet RA, Zhang Z, Wiseman RW, and You M (2000). Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res 26, 581-593.
79. de Seranno S and Meuwissen R (2010). Progress and applications of mouse models for human lung cancer. Eur Respir J 35, 426-443.
80. Wu K, Kim HT, Rodriquez JL, Munoz-Medellin D, Mohsin SK, Hilsenbeck SG, Lamph WW, Gottardis MM, Shirley MA, Kuhn JG, et al. (2000). 9-cis- Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice. Clin Cancer Res 6, 3696-3704.
81. McCormick DL, Johnson WD, Rao KV, Bowman-Gram T, Steele VE, Lubet RA, and Kelloff GJ (1996). Comparative activity of N-(4-hydroxyphenyl)-alltrans- retinamide and α-difluoromethylornithine as inhibitors of lymphoma induction in PIM transgenic mice. Carcinogenesis 17, 2513-2517.
82. Hessel S, Eichinger A, Isken A, Amengual J, Hunzelmann S, Hoeller U, Elste V, Hunziker W, Goralczyk R, Oberhauser V, et al. (2007). CMO1 deficiency abolishes vitamin A production from β-carotene and alters lipid metabolism in mice. J Biol Chem 282, 33553-33561.
83. Ford NA, Clinton SK, von Lintig J, Wyss A, and Erdman JW Jr (2010). Loss of carotene-9′,10′-monooxygenase expression increases serum and tissue lycopene concentrations in lycopene-fed mice. J Nutr 140, 2134-2138.
84. Campbell JK, Stroud CK, Nakamura MT, Lila MA, and Erdman JW Jr (2006). Serum testosterone is reduced following short-term phytofluene, lycopene, or tomato powder consumption in F344 rats. J Nutr 136, 2813-2819.
85. Boileau TW, Clinton SK, and Erdman JW Jr (2000). Tissue lycopene concentrations and isomer patterns are affected by androgen status and dietary lycopene concentration in male F344 rats. J Nutr 130, 1613-1618.
86. Gajic M, Zaripheh S, Sun F, and Erdman JW Jr (2006). Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J Nutr 136, 1552-1557.
87. Paolini M, Cantelli-Forti G, Perocco P, Pedulli GF, Abdel-Rahman SZ, and Legator MS (1999). Co-carcinogenic effect of β-carotene. Nature 398, 760-761.
88. Zhao Z, Khachik F, Richie JP Jr, and Cohen LA (1998). Lycopene uptake and tissue disposition in male and female rats. Proc Soc Exp Biol Med 218, 109-114.
89. Cohen LA (2002). A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med (Maywood) 227, 864-868.
90. Furukawa F, Nishikawa A, Kasahara K, Lee IS, Wakabayashi K, Takahashi M, and Hirose M (1999). Inhibition by β-carotene of upper respiratory tumorigenesis in hamsters receiving diethylnitrosamine followed by cigarette smoke exposure. Jpn J Cancer Res 90, 154-161.
91. Al-Wadei HA and Schuller HM (2009). β-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma. Eur J Cancer 45, 1257-1264.
92. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna- Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, et al. (2001). Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98, 13784-13789.
93. Adissu HA and Schuller HM (2004). Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type II cell lineage: implications for chemoprevention. Int J Oncol 24, 1467-1472.
94. Oreffo VI, Lin HW, Padmanabhan R, and Witschi H (1993). K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. Carcinogenesis 14, 451-455.
95. Schuller HM and Cekanova M (2005). NNK-induced hamster lung adenocarcinomas over-express β2-adrenergic and EGFR signaling pathways. Lung Cancer 49, 35-45.
96. Al-Wadei HA and Schuller HM (2006). Cyclic adenosine monophosphatedependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells. Cancer Detect Prev 30, 403-411.
97. Schuller HM, Witschi HP, Nylen E, Joshi PA, Correa E, and Becker KL (1990). Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia. Cancer Res 50, 1960-1965.
98. Hecht SS and Hoffmann D (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875-884.
99. Koppang N, Rivenson A, Dahle HK, and Hoffmann D (1997). A study of tobacco carcinogenesis, LIII: carcinogenicity of N′-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mink (Mustela vison). Cancer Lett 111, 167-171.
100. van Breemen RB, Xu X, Viana MA, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Bowen PE, and Sharifi R (2002). Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem 50, 2214-2219.
101. Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, Swanson GM, Greenberg RS, Hoover RN, Hayes RB, et al. (2002). Serum lycopene, other serum carotenoids, and risk of prostate cancer in US blacks and whites. Am J Epidemiol 155, 1023-1032.
102. Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, Scher HI, Marshall JR, and Zhang ZF (2001). Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev 10, 749-756.
103. Brady WE, Mares-Perlman JA, Bowen P, and Stacewicz-Sapuntzakis M (1996). Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr 126, 129-137.
104. Marangon K, Herbeth B, Lecomte E, Paul-Dauphin A, Grolier P, Chancerelle Y, Artur Y, and Siest G (1998). Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 67, 231-239.
105. Lee CM, Boileau AC, Boileau TW, Williams AW, Swanson KS, Heintz KA, and Erdman JW Jr (1999). Review of animal models in carotenoid research. J Nutr 129, 2271-2277.
106. Huang CS, Chuang CH, and Hu ML (2006). Effects of lycopene supplementation on plasma and tissue lycopene levels in various rodent strains. Int J Vitamin Nutr Res 76, 377-384.
107. Palozza P and Krinsky NI (1992). Antioxidant effects of carotenoids in vivo and in vitro: an overview. Methods Enzymol 213, 403-420.
108. Handelman GJ, Packer L, and Cross CE (1996). Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. Am J Clin Nutr 63, 559-565.
109. Begum AN and Terao J (2002). Protective effect of quercetin against cigarette tar extract-induced impairment of erythrocyte deformability. J Nutr Biochem 13, 265-272.
110. Wurzel H, Yeh CC, Gairola C, and Chow CK (1995). Oxidative damage and antioxidant status in the lungs and bronchoalveolar lavage fluid of rats exposed chronically to cigarette smoke. J Biochem Toxicol 10, 11-17.
111. Palozza P, Serini S, Trombino S, Lauriola L, Ranelletti FO, and Calviello G (2006). Dual role of β-carotene in combination with cigarette smoke aqueous extract on the formation of mutagenic lipid peroxidation products in lung membranes: dependence on PO2. Carcinogenesis 27, 2383-2391.
112. Krinsky NI and Johnson EJ (2005). Carotenoid actions and their relation to health and disease. Mol Aspects Med 26, 459-516.
113. Wertz K, Siler U, and Goralczyk R (2004). Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430, 127-134.
114. Rao AV, Ray MR, and Rao LG (2006). Lycopene. Adv Food Nutr Res 51, 99-164.
115. Stahl W and Sies H (1996). Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 336, 1-9.
116. Agarwal S and Rao AV (2000). Carotenoids and chronic diseases. Drug Metabol Drug Interact 17, 189-210.
117. Mayne ST, Handelman GJ, and Beecher G (1996). β-Carotene and lung cancer promotion in heavy smokers-a plausible relationship? J Natl Cancer Inst 88, 1513-1515.
118. Arora A, Willhite CA, and Liebler DC (2001). Interactions of β-carotene and cigarette smoke in human bronchial epithelial cells. Carcinogenesis 22, 1173-1178.
119. Weitberg AB and Corvese D (1997). Effect of vitamin E and β-carotene on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes. J Exp Clin Cancer Res 16, 11-14.
120. Bogos K, Renyi-Vamos F, Kovacs G, Tovari J, and Dome B (2008). Role of retinoic receptors in lung carcinogenesis. J Exp Clin Cancer Res 27, 18.
121. Liu C, Russell RM, and Wang XD (2003). Exposing ferrets to cigarette smoke and a pharmacological dose of β-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr 133, 173-179.
122. Karin M, Liu Z, and Zandi E (1997). AP-1 function and regulation. Curr Opin Cell Biol 9, 240-246.
123. Hirsch DD and Stork PJ (1997). Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo. J Biol Chem 272, 4568-4575.
124. Lee HY, Sueoka N, Hong WK, Mangelsdorf DJ, Claret FX, and Kurie JM (1999). All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Mol Cell Biol 19, 1973-1980.
125. Chung J, Chavez PR, Russell RM, and Wang XD (2002). Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats. Oncogene 21, 1539-1547.
126. Liu C, Russell RM, and Wang XD (2004). Low dose β-carotene supplementation of ferrets attenuates smoke-induced lung phosphorylation of JNK, p38, MAPK, and p53 proteins. J Nutr 134, 2705-2710.
127. Palozza P, Simone R, and Mele MC (2008). Interplay of carotenoids with cigarette smoking: implications in lung cancer. Curr Med Chem 15, 844-854.
128. Gradelet S, Leclerc J, Siess MH, and Astorg PO (1996). β-Apo-8′-carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 26, 909-919.
129. Salgo MG, Cueto R, Winston GW, and Pryor WA (1999). β Carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 26, 162-173.
130. Perocco P, Paolini M, Mazzullo M, Biagi GL, and Cantelli-Forti G (1999). β-Carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro. Mutat Res 440, 83-90.
131. Yu H and Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92, 1472-1489.
132. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, and Cohen P (2000). Direct functional interactions between insulin-like growth factorbinding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275, 33607-33613.
133. Giovannucci E (1999). Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 51(suppl 3), 34-41.
134. Saffiotti U, Montesano R, Sellakumar AR, and Borg SA (1967). Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 20, 857-864.
135. Nettesheim P and Williams ML (1976). The influence of vitamin A on the susceptibility of the rat lung to 3-methylcholanthrene. Int J Cancer 17, 351-357.
136. Dahl AR, Grossi IM, Houchens DP, Scovell LJ, Placke ME, Imondi AR, Stoner GD, De Luca LM, Wang D, and Mulshine JL (2000). Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res 6, 3015-3024.
137. Kim DJ, Takasuka N, Kim JM, Sekine K, Ota T, Asamoto M, Murakoshi M, Nishino H, Nir Z, and Tsuda H (1997). Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett 120, 15-22.
138. IARC Working Group on the Evaluation of Cancer Preventive Agents (1998). Carotenoids. In IARC Handbook on Cancer Prevention. IARC, Lyon, France.
139. Paolini M, Antelli A, Pozzetti L, Spetlova D, Perocco P, Valgimigli L, Pedulli GF, and Cantelli-Forti G (2001). Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in β-carotene supplemented rats. Carcinogenesis 22, 1483-1495.